Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
omega-3 fatty acid |
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
gptkb:C10AX06
|
| gptkbp:brand |
gptkb:Epanova
|
| gptkbp:CASNumber |
85666-92-8
|
| gptkbp:chemicalFormula |
C20H30O2 (EPA), C22H32O2 (DHA)
|
| gptkbp:contains |
gptkb:eicosapentaenoic_acid
docosahexaenoic acid |
| https://www.w3.org/2000/01/rdf-schema#label |
omega-3-carboxylic acids
|
| gptkbp:legalStatus |
prescription only (US)
|
| gptkbp:marketedAs |
gptkb:AstraZeneca
|
| gptkbp:mechanismOfAction |
reduces triglyceride synthesis
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
diarrhea abdominal pain |
| gptkbp:usedFor |
treatment of severe hypertriglyceridemia
|
| gptkbp:withdrawn |
2020 (US)
|
| gptkbp:bfsParent |
gptkb:Epanova
|
| gptkbp:bfsLayer |
7
|